Try our beta test site
41 studies found for:    Open Studies | "Testicular Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Testicular Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS
Condition: Testicular Neoplasms
Intervention:
2 Recruiting Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study)
Condition: Testicular Cancer
Intervention:
3 Recruiting Cause of Familial Testicular Cancer
Condition: Testicular Cancer
Intervention:
4 Recruiting The Platinum Study Comparison Group
Condition: Testicular Neoplasms
Intervention: Behavioral: Questionnaire
5 Recruiting Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
Conditions: Testicular Neoplasms;   Seminoma
Interventions: Drug: Bleomycin Etoposide and Cisplatin;   Drug: Carboplatin
6 Recruiting Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
Condition: Testicular Cancer
Interventions: Drug: Veliparib;   Drug: Gemcitabine;   Drug: Carboplatin
7 Recruiting Vascular Fingerprint Validation Study
Condition: Testicular Cancer
Intervention:
8 Recruiting TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects
Condition: Testicular Cancer
Intervention: Other: Vena punction
9 Recruiting Germ Cell Tumor and Testicular Tumor DNA Registry
Conditions: Germ Cell Tumor;   Testicular Tumor
Interventions: Behavioral: Questionnaires;   Other: sample of blood or saliva
10 Recruiting Study of Testosterone vs Placebo in Testicular Cancer Survivors
Conditions: Metabolic Syndrome;   Testicular Cancer;   Leydig Cell Failure in Adult
Interventions: Drug: Testosterone;   Drug: Placebos
11 Recruiting Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer
Condition: Testicular Cancer
Intervention: Drug: cabazitaxel
12 Recruiting Quality of Life Among Testicular Cancer Survivors
Conditions: Testicular Neoplasms;   Spermatic Cord Torsion;   Varicocele;   Testicular Hydrocele
Interventions: Other: Questionnaires;   Other: Hormonal Function measurement
13 Recruiting High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors
Condition: Testicular Cancer
Interventions: Drug: Gemcitabine;   Drug: Docetaxel;   Drug: Melphalan;   Drug: Carboplatin;   Drug: Mesna;   Drug: Ifosfamide;   Drug: Etoposide;   Procedure: Stem Cell Transplant
14 Recruiting Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy
Conditions: Peripheral Nervous System Diseases;   Testicular Neoplasms
Interventions: Procedure: Blood sample collection;   Behavioral: Report of peripheral neuropathy after cisplatin therapy
15 Recruiting Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell Cancer
Condition: Testicular Germ Cell Cancer
Intervention: Device: Aerobic program
16 Recruiting Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study
Conditions: Breast Cancer;   Testicular Cancer
Intervention: Other: Literature search and semi-structured interview
17 Recruiting Autologous Dendritic Cell Vaccine Loaded With Allogeneic Tumor Lysate Expression of Cancer Testis Antigens in Patients With Soft Tissue Sarcoma
Conditions: Sarcoma;   Neoplasms, Connective and Soft Tissue
Intervention: Biological: Autologous dendritic cell vaccine
18 Recruiting Study of the Hypomethylating Drug SGI-110 Plus Cisplatin in Relapsed Refractory Germ Cell Tumors
Conditions: Germ Cell Tumor;   Testis Cancer;   Testicular Cancer
Intervention: Drug: SGI-110
19 Recruiting Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Conditions: Germ Cell Tumors;   Testis Cancer;   Testicular Cancer;   Embryonal Carcinoma;   Nonseminomatous Germ Cell Tumor
Intervention: Drug: Brentuximab Vedotin
20 Recruiting Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)
Condition: Stage II A/B Seminomatous Germ Cell Tumors
Intervention: Procedure: Primary retroperitoneal lymph-node dissection (pRPLND)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.